abstract |
The present invention provides a chimeric antibody immune cell activator comprising a target cell binding domain that specifically binds to an antigen on a target cell, and an immune effector cell binding domain comprising a binding moiety for the antigen that specifically binds to an antigen on an immune effector cell. The invention also relates to pharmaceutical compositions, kits and methods of treatment. |